Successful treatment of generalized essential telangiectasia with 6-mercaptopurine

Alex M. Glazer; Bryan D. Sofen; Darrell S. Rigel; Jerome L. Shupack

Successful treatment of generalized essential telangiectasia with 6-mercaptopurine

Alex M. Glazer
, Bryan D. Sofen
, Darrell S. Rigel
, Jerome L. Shupack

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

Generalized essential telangiectasia (GET) is a notoriously difficult to treat disorder with no current satisfactory treatments. This case and discussion report the use of 6-mercaptopurine (6-MP) as a successful treatment for GET. Moreover, we show that GET may represent a state of increased angiogenesis, a paradigm shift from the current understanding that these telangiectasias represent dilatations of only preexisting vessels. This new view of GET may drive others to look at novel agents for treatment.

Original language	English
Pages (from-to)	280-282
Number of pages	3
Journal	Journal of Drugs in Dermatology
Volume	16
Issue number	3
State	Published - Mar 2017
Externally published	Yes

Cite this

@article{1798d94e032141c09821a6aedffdad6f,

title = "Successful treatment of generalized essential telangiectasia with 6-mercaptopurine",

abstract = "Generalized essential telangiectasia (GET) is a notoriously difficult to treat disorder with no current satisfactory treatments. This case and discussion report the use of 6-mercaptopurine (6-MP) as a successful treatment for GET. Moreover, we show that GET may represent a state of increased angiogenesis, a paradigm shift from the current understanding that these telangiectasias represent dilatations of only preexisting vessels. This new view of GET may drive others to look at novel agents for treatment.",

author = "Glazer, \{Alex M.\} and Sofen, \{Bryan D.\} and Rigel, \{Darrell S.\} and Shupack, \{Jerome L.\}",

year = "2017",

month = mar,

language = "English",

volume = "16",

pages = "280--282",

journal = "Journal of Drugs in Dermatology",

issn = "1545-9616",

publisher = "Journal of Drugs in Dermatology",

number = "3",

}

TY - JOUR

T1 - Successful treatment of generalized essential telangiectasia with 6-mercaptopurine

AU - Glazer, Alex M.

AU - Sofen, Bryan D.

AU - Rigel, Darrell S.

AU - Shupack, Jerome L.

PY - 2017/3

Y1 - 2017/3

N2 - Generalized essential telangiectasia (GET) is a notoriously difficult to treat disorder with no current satisfactory treatments. This case and discussion report the use of 6-mercaptopurine (6-MP) as a successful treatment for GET. Moreover, we show that GET may represent a state of increased angiogenesis, a paradigm shift from the current understanding that these telangiectasias represent dilatations of only preexisting vessels. This new view of GET may drive others to look at novel agents for treatment.

AB - Generalized essential telangiectasia (GET) is a notoriously difficult to treat disorder with no current satisfactory treatments. This case and discussion report the use of 6-mercaptopurine (6-MP) as a successful treatment for GET. Moreover, we show that GET may represent a state of increased angiogenesis, a paradigm shift from the current understanding that these telangiectasias represent dilatations of only preexisting vessels. This new view of GET may drive others to look at novel agents for treatment.

UR - https://www.scopus.com/pages/publications/85028972070

M3 - Article

C2 - 28301625

AN - SCOPUS:85028972070

SN - 1545-9616

VL - 16

SP - 280

EP - 282

JO - Journal of Drugs in Dermatology

JF - Journal of Drugs in Dermatology

IS - 3

ER -

Successful treatment of generalized essential telangiectasia with 6-mercaptopurine

Abstract

Fingerprint

Cite this